WJ

Waman Jogi

Active Director Director DIN 10483174
DIN 10483174 First appointment Jan 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value •••• Premium profile

About Waman Jogi

Data last updated:

Waman Jogi is a Director at Horster Biotek Private Limited (since 2024). The company operates in Pharma. Horster Biotek Private Limited reported revenue of ₹9.25 Cr (FY 2025).

DIN 10483174
Primary Designation Director
Industry Pharma
First Appointment 31 Jan 2024
Oldest Company Age 15 yrs
Largest company Horster Biotek Private Limited · ₹9.25 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Horster Biotek Private Limited U24232MP2010PTC024892
Director31 Jan 20242010₹9.25 Cr (FY 2025)Active

Board colleagues of Waman Jogi

NameDINCompanyDesignation
Mehul Niranjan Jhaveri03194727Horster Biotek Private LimitedDirector

Directorship timeline

Open interactive timeline →
Horster Biotek Private Limited
Premium access

Shareholding and investment profile for Waman Jogi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Waman Jogi

Waman Jogi currently holds 1 directorship: Horster Biotek Private Limited (Director, since 31 Jan 2024, revenue ₹9.25 Cr (FY 2025)).

Waman Jogi was first appointed on 31 Jan 2024 as Director at Horster Biotek Private Limited.

The current boards of Waman Jogi's companies include Mehul Niranjan Jhaveri (Horster Biotek Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available